Profile data is unavailable for this security.
About the company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
- Revenue in USD (TTM)0.00
- Net income in USD-33.23m
- Incorporated2020
- Employees12.00
- LocationSeaStar Medical Holding Corp3513 Brighton Blvd, Suite 410DENVER 80216United StatesUSA
- Phone+1 (813) 362-6488
- Fax+1 (302) 655-5049
- Websitehttps://seastarmedical.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Precipio Inc | 16.72m | -3.83m | 9.10m | 51.00 | -- | 0.7448 | -- | 0.5444 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 9.15m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 9.16m | 113.00 | -- | -- | -- | 1.28 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 9.44m | 53.00 | -- | 0.1554 | -- | 2.78 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| PetVivo Holdings Inc | 975.28k | -10.11m | 9.80m | 20.00 | -- | 11.76 | -- | 10.05 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 10.24m | -- | -- | 0.471 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 10.26m | 6.00 | -- | 17.84 | -- | 70.82 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| Guided Therapeutics Inc | 38.00k | -2.39m | 10.78m | 4.00 | -- | -- | -- | 283.66 | -0.0444 | -0.0444 | 0.0007 | -0.0829 | 0.0211 | 0.0365 | 8.44 | 9,500.00 | -120.81 | -136.13 | -- | -- | 42.11 | 29.39 | -5,721.05 | -3,666.67 | 0.0679 | -7.58 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Innovative Eyewear Inc | 1.53m | -7.86m | 10.90m | 11.00 | -- | 1.44 | -- | 7.13 | -11.01 | -11.01 | 2.05 | 4.81 | 0.1779 | 1.97 | 15.91 | 139,070.90 | -91.45 | -- | -96.06 | -- | -2.46 | -- | -514.10 | -- | 12.85 | -- | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Golden Valley Development Inc | 0.00 | -92.53k | 11.63m | 0.00 | -- | -- | -- | -- | -11.17 | -11.17 | 0.00 | -0.0211 | 0.00 | -- | -- | -- | -7,710.83 | -- | -- | -- | -- | -- | -- | -3,073.27 | -- | -3.96 | -- | -- | -- | -- | 45.48 | -- | -- | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.23m | 11.65m | 12.00 | -- | -- | -- | -- | -21.41 | -21.41 | 0.00 | -2.14 | 0.00 | -- | -- | 0.00 | -1,145.80 | -- | -- | -- | -- | -- | -- | -- | -- | -9.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| PAVmed Inc | 3.83m | -67.35m | 11.66m | 107.00 | -- | -- | -- | 3.04 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| Autonomix Medical Inc | -100.00bn | -100.00bn | 12.21m | 5.00 | -- | 1.93 | -- | -- | -- | -- | -- | 5.50 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.1647 | -- | -- | -- | -674.99 | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.73m | -8.31m | 12.81m | 99.00 | -- | 1.13 | -- | 0.3913 | -2.37 | -2.37 | 9.35 | 2.71 | 0.6906 | 3.47 | 7.81 | 330,606.10 | -17.54 | -11.48 | -24.26 | -16.55 | 54.30 | 61.28 | -25.40 | -17.70 | 0.9176 | -2.69 | 0.6141 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| BioRegenx Inc | 1.29m | -4.28m | 12.96m | 10.00 | -- | 0.9114 | -- | 10.03 | -0.0053 | -0.0053 | 0.0023 | 0.0149 | 0.1438 | -- | -- | 129,234.00 | -47.59 | -- | -58.94 | -- | 66.76 | -- | -331.00 | -- | 0.0533 | -28.81 | 0.1284 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| Meihua International Medical Tech Co Ltd | 94.25m | 9.28m | 14.10m | 617.00 | 1.45 | 0.0872 | 1.45 | 0.1496 | 0.3442 | 0.3442 | 3.45 | 5.73 | 0.5516 | 46.02 | 1.16 | 152,759.40 | 5.42 | 12.26 | 6.43 | 15.05 | 33.12 | 38.14 | 9.84 | 15.47 | 4.74 | -- | 0.0729 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
Data as of Nov 13 2024. Currency figures normalised to SeaStar Medical Holding Corp's reporting currency: US Dollar USD
3.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BofA Securities, Inc.as of 30 Jun 2024 | 33.37k | 0.80% |
| Geode Capital Management LLCas of 30 Jun 2024 | 31.02k | 0.74% |
| UBS Securities LLCas of 30 Jun 2024 | 29.06k | 0.69% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 26.02k | 0.62% |
| Thoroughbred Financial Services LLCas of 30 Sep 2024 | 11.23k | 0.27% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 9.13k | 0.22% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 7.70k | 0.18% |
| Barclays Bank Plc (Private Banking)as of 30 Jun 2024 | 5.83k | 0.14% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 4.20k | 0.10% |
| Vanguard Global Advisers LLCas of 30 Jun 2024 | 1.64k | 0.04% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
